BUPIVAKAINHYDROKLORID BAXTER 5 mg/ml injektioneste, liuos Finnland - finnska - Fimea (Suomen lääkevirasto)

bupivakainhydroklorid baxter 5 mg/ml injektioneste, liuos

baxter oy - bupivacaini hydrochloridum - injektioneste, liuos - 5 mg/ml - bupivakaiini

HUMAN ALBUMIN BAXTER 200 mg/ml infuusioneste, liuos Finnland - finnska - Fimea (Suomen lääkevirasto)

human albumin baxter 200 mg/ml infuusioneste, liuos

baxter ag - albuminum ihmisen - infuusioneste, liuos - 200 mg/ml - albumiini

FLUCONAZOLE BAXTER 2 mg/ml infuusioneste, liuos Finnland - finnska - Fimea (Suomen lääkevirasto)

fluconazole baxter 2 mg/ml infuusioneste, liuos

baxter oy - fluconazolum - infuusioneste, liuos - 2 mg/ml - flukonatsoli

CIPROFLOXACIN BAXTER 2 mg/ml infuusioneste, liuos Finnland - finnska - Fimea (Suomen lääkevirasto)

ciprofloxacin baxter 2 mg/ml infuusioneste, liuos

baxter oy - ciprofloxacinum - infuusioneste, liuos - 2 mg/ml - siprofloksasiini

NATRIUMKLORID BAXTER VIAFLO 4.5 mg/ml infuusioneste, liuos Finnland - finnska - Fimea (Suomen lääkevirasto)

natriumklorid baxter viaflo 4.5 mg/ml infuusioneste, liuos

baxter oy - natrii chloridum - infuusioneste, liuos - 4.5 mg/ml - natriumkloridi

Celdoxome pegylated liposomal Evrópusambandið - finnska - EMA (European Medicines Agency)

celdoxome pegylated liposomal

yes pharmaceutical development services gmbh - doksorubisiinihydrokloridia - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastiset aineet - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).

Artiss liuokset kudosliimaa varten Finnland - finnska - Fimea (Suomen lääkevirasto)

artiss liuokset kudosliimaa varten

baxter oy - calcium chloride dihydrate, human fibrinogen, aprotinine, human thrombin - liuokset kudosliimaa varten - yhdistelmävalmisteet

Plasmalyte infuusioneste, liuos Finnland - finnska - Fimea (Suomen lääkevirasto)

plasmalyte infuusioneste, liuos

baxter oy - potassium chloride, magnesium chloride hexahydrate, sodium acetate trihydrate, sodium chloride, sodium gluconate - infuusioneste, liuos - elektrolyytit

Plasmalyte Glucos 50 mg/ml infuusioneste, liuos Finnland - finnska - Fimea (Suomen lääkevirasto)

plasmalyte glucos 50 mg/ml infuusioneste, liuos

baxter oy - glucose monohydrate, potassium chloride, magnesium chloride hexahydrate, sodium acetate trihydrate, sodium chloride, sodium gluconate - infuusioneste, liuos - 50 mg/ml - elektrolyytit ja hiilihydraatit

HEPAFLEX 2.5 IU/ml infuusioneste, liuos Finnland - finnska - Fimea (Suomen lääkevirasto)

hepaflex 2.5 iu/ml infuusioneste, liuos

baxter s.a. - heparinum natricum - infuusioneste, liuos - 2.5 iu/ml - hepariini